2018 International Congress » Therapy in Movement Disorders: Gene and Cell-Based Therapies

Date: Saturday, October 6, 2018

Time: 1:45pm-3:15pm

Location: Hall 3FG

Meeting: 2018 International Congress

1:45pm-3:15pm: An investigation of the potential neuroprotective role of curcumin in Parkinson’s disease patient-derived fibroblasts

S. Abrahams, C. vander Merwe, A. Neethling, J. Carr, S. Bardien (Cape Town, South Africa)

1:45pm-3:15pm: Biofabricated tissue constructs to recapitulate the anatomy and functionality of the nigrostriatal pathway in Parkinson’s disease

J. Duda, L. Struzyna, K. Browne, H. Chen, D. Cullen (Philadelphia, PA, USA)

1:45pm-3:15pm: Modified Frameless Stereotaxy for Gene Therapy in Pediatric Movement Disorder Patients

CH. Tai, SH. Tseng, RM. Wu, WL. Hwu (Taipei, Taiwan)

1:45pm-3:15pm: Preclinical evaluation of a novel autologous substrate for cell-based therapy

S. Benoit, H. Xu, J. Ronald, P. Foster, S. Schmid, M. Hebb (London, ON, Canada)

1:45pm-3:15pm: Transplantation therapy of human iPS cell-derived dopamine neural progenitor cells for Parkinson’s disease

R. Nakamura, G. Oyama, T. Jo, K. Ishikawa, R. Nonaka, Y. Shimo, W. Akamatsu, N. Hattori (Tokyo, Japan)

1:45pm-3:15pm: Vitamin B3 and Neurodevelopment in Parkinson’s Disease

A. Williams, S. Griffin, R. Fricker (Birmingham, United Kingdom)

« View all sessions from the 2018 International Congress.